CG Oncology, Inc. (CGON) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts CGON Hot Sheet
Join SI Premium – FREE
CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.30), $0.12 better than the analyst estimate of ($0.42).
For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Committee Recommends To Widen Access To Bpc-157 Peptide
- ACNB Corporation (ACNB) Tops Q2 EPS by 11c
- AMD Announces Helios AI Server Computer Rack
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
